Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, will host a webinar ...

The All India Institute of Medical Sciences (AIIMS), Delhi, and five other medical centres will study 200 families over the ...

Argenx (ENXTBR:ARGX) reported positive topline Phase 3 ALKIVIA trial results for VYVGART in autoimmune myositis patients. The ...

The ALKIVIA trial was a global, randomized, double-blind, placebo-controlled, multicenter, operationally seamless Phase 2/3 study of efgartigimod SC for the treatment of autoimmune myositis across ...

Actor Samantha Ruth Prabhu has announced that she is expecting her first child with filmmaker Raj Nidimoru after battling myositis, a rare autoimmune muscle disorder, for nearly three years. The news ...

argenx stock enters a key clinical week ahead of new ALKIVIA results in autoimmune myositis. The presentation is set for ...

TMA’s innovative, nutrition-focused research proposal is one of 15 projects selected in crowd-sourced search for ideas to reduce autoimmune disease burden. The proposal was created through extensive ...

argenx remains a dominant player in the anti-FcRn market, with Vyvgart approved for gMG, CIDP, and ITP in Japan. The ALKIVIA trial aims to expand Vyvgart's use in myositis, a rare autoimmune disease ...

Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained ...

Polymyositis (PM) and dermatomyositis (DM) may involve the striated muscle of the esophagus, leading to abnormal swallowing that in turn can lead to malnutrition and/or aspiration. Esophageal disease ...

Q3 2026 Financial Results and Business Update Conference Call and Webcast Scheduled for November 5, 2026 at 2:00 p.m. PT/5:00 p.m. ETALLO-329 ...